Kidswell Bio CorporationTSE 4584

キッズウェル・バイオ株式会社 · Pharmaceutical · FY ends Mar

Share price at FY-end
—
FY ending Mar 2026
Market cap at FY-end
—
Dividend per share
—
Avg. director pay
¥24.7M
Internal directors

Top 10 shareholders

#ShareholderSharesStakeValueDividends
1 ノーリツ鋼機株式会社 9,471,832 19.08% — —
2 江平 文茂 2,000,000 4.03% — —
3 NANO ホールディングス株式会社 1,000,000 2.01% — —
4 楽天証券株式会社共有口 792,600 1.59% — —
5 千寿製薬株式会社 555,200 1.11% — —
6 野村信託銀行株式会社 471,000 0.94% — —
7 北島 義彦 445,000 0.89% — —
8 BNY GCM CLIENT ACCOUNT JPRD AC ISG 440,600 0.88% — —
9 津田 謹誠 436,800 0.88% — —
10 大友 宏一 400,050 0.80% — —

Officers' holdings and pay

NameTitleSharesValuePay
紅林 伸也 President & Representative Director 91,000 — —
栄木 憲和 Director — — —
西岡 佐知子 Director — — —
菅原 治 Full-time Audit & Supervisory Board Member 6,200 — —
森 正人 Audit & Supervisory Board Member 2,300 — —
品川 広志 Audit & Supervisory Board Member 23,100 — —

Pay is shown only for officers whose pay of ¥100 million or more is disclosed individually.

Per-share data by fiscal year

Fiscal yearPriceEPSP/EDividendShares issued
FY ending Mar 2026 — ¥-8.48 41.2x — 49,623,419
FY ending Mar 2025 — ¥-0.52 7.9x — 43,881,013
FY ending Mar 2024 — ¥-40.23 — — 38,939,913
FY ending Mar 2023 — ¥-20.77 — — 32,059,713
FY ending Mar 2022 — ¥-17.35 — — 31,437,547
Source: annual securities reports on EDINET. Values are estimates. Methodology